Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

66
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
66
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

881
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
881
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

498
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
498
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

41
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anthropometry, sex, and age at diagnosis affect pulmonary blood volume quantification from computed tomography pulmonary angiography in pulmonary hypertension assessment.

Frontiers in cardiovascular medicine·2026
Same author

Reply to Sun et al.: defining the translational validity of CTPA-derived pulmonary blood volume in CTEPH.

American journal of respiratory cell and molecular biology·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy.

American journal of respiratory cell and molecular biology·2026
Same author

Pulmonary blood volumes on computed tomography predict residual pulmonary hypertension post-pulmonary endarterectomy.

American journal of respiratory cell and molecular biology·2025
Same author

Deep Learning-based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2024

Related Experiment Video

Updated: Oct 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.4K

Update on sarcoidosis guidelines.

Kate Millward1, Christine A Fiddler2, Muhunthan Thillai2,3

  • 1Respiratory Sleep and Support Centre, Royal Papworth Hospital.

Current Opinion in Pulmonary Medicine
|July 14, 2021
PubMed
Summary

New guidelines for sarcoidosis diagnosis and management emphasize multidisciplinary teams and updated biopsy approaches. Treatment strategies now include specific guidance for cardiac sarcoidosis and managing fatigue.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

582
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

3.7K

Related Experiment Videos

Last Updated: Oct 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.4K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

582
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

3.7K

Area of Science:

  • Pulmonology
  • Internal Medicine
  • Rheumatology

Background:

  • The 1999 International Statement on Sarcoidosis was the primary guideline for diagnosis and management.
  • Recent advancements necessitated updated recommendations, leading to new guidelines in 2020.

Purpose of the Study:

  • To summarize key updates from the 2020 American and British Thoracic Societies' guidelines for sarcoidosis.
  • To provide an overview of recent diagnostic and management strategies for sarcoidosis.

Main Methods:

  • Review of the 2020 American and British Thoracic Societies' guidelines.
  • Synthesis of information on diagnostic criteria, biopsy techniques, supportive tests, cardiac sarcoidosis, and treatment.

Main Results:

  • Histological diagnosis is recommended for uncertain cases, with specific biopsy pathways based on imaging findings.
  • Guidelines address multidisciplinary team involvement, blood biomarkers, lung function, imaging, and cardiac sarcoidosis.
  • Treatment guidance includes steroid regimens and indications for second-line immunosuppression, with attention to fatigue management.

Conclusions:

  • The 2020 guidelines offer a refined approach to sarcoidosis diagnosis, emphasizing histological confirmation when needed and tailored biopsy strategies.
  • Updated management recommendations provide a clearer framework for treatment, including specific considerations for cardiac involvement and patient-reported symptoms like fatigue.